Jose Maria Garcia-Bueno

Deletion at 6q24.2–26 predicts longer survival of high‐grade serous epithelial ovarian cancer patients

Marta Kamieniak, Daniel Rico, Roger L. Milne et al. · Molecular Oncology · 2014 · 35 citations · Full text

Medicine, Molecular Genetics, Oncology +16

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

Matthew S. Block, Robert A. Vierkant, Peter Rambau et al. · Mayo Clinic Proceedings · 2018 · 30 citations · Full text

Medicine, Oncology, Pathology +17

The NER-related gene <i>GTF2H5</i> predicts survival in high-grade serous ovarian cancer patients

Javier Machín Gayarre, Marta Kamieniak, Iván Muñoz‐Repeto et al. · Journal of Gynecologic Oncology · 2015 · 29 citations · Full text

Medicine, Molecular Biology, Oncology +17

DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas

Marta Kamieniak, Iván Muñoz‐Repeto, Daniel Rico et al. · British Journal of Cancer · 2013 · 25 citations · Full text

Medicine, Genetics, Oncology +17

A Phase II Study of Weekly Vinorelbine and Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer

Juan Bayo-Calero, José Mayordomo, Pedro Sánchez‐Rovira et al. · Clinical Breast Cancer · 2008 · 23 citations

Medicine, Oncology, Pharmacology +16